Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques|August 19, 2014
Tissue kallikrein-kinin therapy in hypertension and organ damageJulie Chao, Grant Bledsoe, Lee Chao
World Journal of Stem Cells|September 27, 2014
Kallikrein-kinin in stem cell therapyJulie Chao, Grant Bledsoe, Lee Chao
American Journal of Physiology. Heart and Circulatory Physiology|June 21, 2003
Kallikrein gene delivery attenuates cardiac remodeling and promotes neovascularization in spontaneously hypertensive ratsGrant Bledsoe, Lee Chao, Julie Chao
American Journal of Physiology. Renal Physiology|May 12, 2005
Kallikrein gene transfer reduces renal fibrosis, hypertrophy, and proliferation in DOCA-salt hypertensive ratsChun-Fang Xia, Grant Bledsoe, Lee Chao, et al.
Kidney International|July 16, 2004
Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stressJenny J Zhang, Grant Bledsoe, Kazuo Kato, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 14, 2009
Intermedin is a new angiogenic growth factorRobert S Smith, Lin Gao, Grant Bledsoe, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 24, 2013
Tissue kallikrein-modified mesenchymal stem cells provide enhanced protection against ischemic cardiac injury after myocardial infarctionLin Gao, Grant Bledsoe, Hang Yin, et al.
American Journal of Physiology. Renal Physiology|July 20, 2012
Depletion of endogenous kallistatin exacerbates renal and cardiovascular oxidative stress, inflammation, and organ remodelingYuying Liu, Grant Bledsoe, Makato Hagiwara, et al.
Molecular and Cellular Biochemistry|May 14, 2013
Kallistatin antagonizes Wnt/β-catenin signaling and cancer cell motility via binding to low-density lipoprotein receptor-related protein 6Jingmei Zhang, Zhirong Yang, Pengfei Li, et al.
Pageof 3